More than three decades ago, neurosurgeons first investigated the use of deep brain stimulation (DBS) to relieve severe body tremors in patients battling the neurological disorder Parkinson’s disease.
In 1997, the Food and Drug Administration officially approved DBS for tremors. Fifteen years later, its effects are still not completely understood.
For Diana Sidtis, Steinhardt School of Culture, Education, and Human Development professor of communicative sciences and disorders, and her husband, John J. Sidtis, research professor in the Department of Psychiatry at the NYU School of Medicine, the mystery of how DBS affects the “low, soft, and breathy” speech of those living with the illness remains a driving force behind their research. Thanks to a $2.2 million grant from the National Institutes of Health, they can continue their search for answers.
“Parkinson’s patients have movement disorders, tremors, or slowness of movement that result in speech problems,” Diana Sidtis explains. “Through previous studies, we found that Parkinson’s disease is characterized by greater difficulty speaking in spontaneous ‘normal’ conversation, with poorer voice quality and fluency. Yet in repetition, where patients are repeating the statements and words of another, voice quality and fluency are improved. DBS improves voice quality to the same extent that repetition does, but fluency is sometimes reduced. So what remains is how and why this is possible.
Cannot serve request to /content/nyu/en/about/news-publications/news/2012/september/husband-and-wife-research-team-at-nyu-receives-grant-to-study-speech-in-parkinsons-sufferers.html on this server
ApacheSling/2.2 (Day-Servlet-Engine/4.1.52, Java HotSpot(TM) 64-Bit Server VM 1.7.0_79, Linux 2.6.32-642.3.1.el6.centos.plus.x86_64 amd64)